Clinical Trials Browser

Phase 4 × Varenicline × 90 days × Clear all

NCT02162849 2026-02-09

Reward Sensitivity and Pharmacotherapy for Smoking Cessation

Phase 4 Active not recruiting

Smoking Cessation, Tobacco Use Cessation